Skip to content

Point of Care UltraSound (POCUS) Use for Intravenous Catheter Placement During Pediatric Interfacility Transport

Point of Care UltraSound (POCUS) Use for Intravenous Catheter Placement During Pediatric Interfacility Transport

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04875988
Enrollment
66
Registered
2021-05-06
Start date
2021-10-31
Completion date
2022-12-31
Last updated
2021-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous Access

Keywords

pediatrics, interfacility transport, intravenous access, ultrasound, POCUS

Brief summary

This study will determine the efficacy of POCUS (Point of Care UltraSound) for intravenous (IV) access during pediatric interfacility transport. The Butterfly iQ+ (Lightning) device will be used. Children requiring IV access for transport will be randomized to POCUS-Assisted IV placement or traditional IV placement. We will examine and compare first attempt success rates with each method.

Interventions

PROCEDUREButterfly iQ+ Ultrasound

ultrasound will be used in the intervention group for IV access

PROCEDURETraditional

ultrasound will not be used in the traditional IV placement group

Sponsors

Arkansas Children's Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Weeks to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Pediatric patients requiring IV access prior to transport by the Angel One Transport Team back to Arkansas Children's Hospital * Age group: 2 weeks - 18 years

Exclusion criteria

* Adequate IV Access * NICU transports * Patients not needing IV access

Design outcomes

Primary

MeasureTime frame
First Attempt IV success rates1 day of transfer

Secondary

MeasureTime frameDescription
Beside Times during transportup to 24 hoursas reported (in minutes)

Contacts

Primary ContactMichael H Stroud, MD
StroudMichaelH@uams.edu501-364-1861

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026